title: Should induction chemotherapy be considered for all patients with gastric cancer?
abstract: An overall response rate of 70% is reported with systemic chemotherapy in gastric cancer, with 13% complete responses. Systemic chemotherapy should now be considered for all patients with gastric cancer, but its use should be prudent and in the context of clinical trials.
authors.affiliation: CRC Section of Medicine, Royal Marsden Hospital, Sutton, Surrey, UK.
authors.forename: T F
authors.initials: TF
authors.lastname: Hickish
authors.forename: D
authors.initials: D
authors.lastname: Cunningham
mesh_terms: D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D006801:Humans; D012074:Remission Induction; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery